Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Conti

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Frontiers in Medicine|December 27, 2023
Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's DiseaseAntonio Vitale, Valeria Caggiano, Petros P Sfikakis, et al.
Rheumatology (Oxford, England)|April 2, 2025
Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network RegistryAntonio Vitale, Valeria Caggiano, Jessica Sbalchiero, et al.
Frontiers in Medicine|July 3, 2023
A patient-driven registry on Behçet's disease: the AIDA for patients pilot projectCarla Gaggiano, Alessandra Del Bianco, Jurgen Sota, et al.
RMD Open|December 6, 2023
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registryAntonio Vitale, Valeria Caggiano, Giuseppe Lopalco, et al.
Seminars in Arthritis and Rheumatism|July 30, 2023
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease RegistryPiero Ruscitti, Jurgen Sota, Antonio Vitale, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2024
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis NephritisSean J Barbour, Rosanna Coppo, Lee Er, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2024
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Frontiers in Immunology|May 27, 2024
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registriesAntonio Vitale, Valeria Caggiano, Abdurrahman Tufan, et al.
The Journal of Rheumatology|November 15, 2024
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease RegistryPiero Ruscitti, Ilenia Di Cola, Antonio Vitale, et al.
Internal and Emergency Medicine|December 27, 2023
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease RegistryPaola Triggianese, Antonio Vitale, Giuseppe Lopalco, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Frontiers in Medicine|December 27, 2023
Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's DiseaseAntonio Vitale, Valeria Caggiano, Petros P Sfikakis, et al.
Rheumatology (Oxford, England)|April 2, 2025
Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network RegistryAntonio Vitale, Valeria Caggiano, Jessica Sbalchiero, et al.
Frontiers in Medicine|July 3, 2023
A patient-driven registry on Behçet's disease: the AIDA for patients pilot projectCarla Gaggiano, Alessandra Del Bianco, Jurgen Sota, et al.
RMD Open|December 6, 2023
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registryAntonio Vitale, Valeria Caggiano, Giuseppe Lopalco, et al.
Seminars in Arthritis and Rheumatism|July 30, 2023
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease RegistryPiero Ruscitti, Jurgen Sota, Antonio Vitale, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2024
Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis NephritisSean J Barbour, Rosanna Coppo, Lee Er, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2024
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Frontiers in Immunology|May 27, 2024
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registriesAntonio Vitale, Valeria Caggiano, Abdurrahman Tufan, et al.
The Journal of Rheumatology|November 15, 2024
Evaluation of Myocarditis in Patients With Still Disease: Clinical Findings From the Multicenter International AIDA Network Still Disease RegistryPiero Ruscitti, Ilenia Di Cola, Antonio Vitale, et al.
Internal and Emergency Medicine|December 27, 2023
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease RegistryPaola Triggianese, Antonio Vitale, Giuseppe Lopalco, et al.
Pageof 10